Work

Supplementary Table 1 from Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file, 60K, MK-2206 treatment and protein response.

DOI: 10.1158/1078-0432.22446321

Authors: Takafumi Sangai, Argun Akcakanat, Huiqin Chen, Emily Tarco, Yun Wu, Kim-Anh Do, Todd W. Miller, Carlos L. Arteaga, Gordon B. Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361902708

Cites:

Cited by:

Related to: 10